Public
Event Title
OTC Monograph Drug User Fee Program (OMUFA): Understanding FY 2021 User Fees Webinar
June 3, 2021
- Date:
- June 3, 2021
- Time:
-
1:00 PM - 2:00 PM ET
Attend
ABOUT
FDA will provide an overview of the Over-The-Counter Monograph Drug User Fee Program (OMUFA) and describe the key elements of the program as it relates to OMUFA user fees.
TOPICS COVERED
- Provide an overview of OMUFA as it relates to user fees
- Discuss the registration process for over-the-counter monograph drug facilities
- Describe the different fee types for OMUFA
- Discuss fiscal year 2021 target revenue, fee rates, and timelines
- Discuss the penalties associated with failure to pay OMUFA user fees
- Provide an overview of the fee payment process
- Discuss OMUFA refund eligibility
FDA SPEAKERS
CAPT Teresa Ramson, Pharm.D., MBA, RAC
Deputy Director, Division of User Fee Management (DUFM)
Office of Management (OM) | CDER | FDA
CAPT Matt Brancazio, Pharm.D., MBA, RAC
Branch Chief, Policy and Operations Branch
DUFM | OM | CDER | FDA
LCDR Tramara Dam, Pharm.D., GWCPM
Program Management Officer, Policy and Operations Branch
DUFM | OM | CDER | FDA
INTENDED AUDIENCE
- Regulatory affairs professionals working on over-the-counter monograph drug products and/or non-prescription drugs or who submit over-the-counter monograph order requests
- Industry partners following the FDA’s implementation of the Over-the-Counter Monograph Drug User Fee Program known as OMUFA
- General public with an interest in over-the-counter monograph drug products and/or non-prescription drugs
- Researchers testing over-the-counter monograph drug products and/or non-prescription drugs
- Foreign regulators of over-the-counter monograph drug products and/or non-prescription drugs
- Consultants focused on processing, manufacturing, developing of over-the-counter monograph drug products and/or non-prescription drugs
- Clinical research coordinators
- Healthcare professionals specializing in over-the-counter monograph drug products or non-prescription drugs
- Importers of over-the-counter monograph drug products and/or non-prescription drugs
- Supply chain of over-the-counter monograph drug products and/or non-prescription drugs
FDA RESOURCES
- Over-The-Counter Monograph User Fee Program (OMUFA)
- OMUFA Cover Sheet and Payment Information
- An Exciting New Chapter in OTC Drug History: OTC Monograph Reform in the CARES Act
- May 29, 2020, Webinar titled: Monograph Reform is Here!
- Over-the-Counter Monograph User Fee Program Performance Goals and Procedures - Fiscal Years 2018-2022
- FDA on Signing of the COVID-19 Emergency Relief Bill, Including Landmark Over-the-Counter Drug Reform and User Fee Legislation
CONTINUING EDUCATION
Real-time attendance is required for the certificate of attendance which can be used in support of CEs for the following professional organizations. Certificates are only available during the two weeks post-event.
This course:
- has been pre-approved by RAPS as eligible for credits (appropriate to real-time attendance) towards a participant’s RAC recertification upon full completion.
- has been pre-approved by SOCRA who accepts documentation of candidate participation in continuing education programs for re-certification if the program is applicable to clinical research regulations, operations or management, or to the candidate's clinical research therapeutic area.
- has been pre-approved by SQA as eligible for 1 non-GCP or non-GLP unit for every 1 hour of instructional time towards a participant’s RQAP re-registration.
- has been approved by ACRP for continuing education in clinical research. ACRP will provide 1 ACRP contact hour for every 45-60 minutes of qualified material.
TECHNICAL INFORMATION AND QUESTIONS
- To optimize webinar experience, use Chrome when viewing AdobeConnect in a browser.
- Please contact info@sbiaevents.com for all technical questions.
- If you encounter any technical issues before or during the event, please visit the Technical Issues Support
- Test your PC for use with Adobe Connect prior to the day of the event. https://concerted.adobeconnect.com/common/help/en/support/meeting_test.htm
Adobe, the Adobe logo, Acrobat and Acrobat Connect are either registered trademarks or trademarks of Adobe Systems Incorporated in the United States and/or other countries.